Free Trial

This company has been marked as potentially delisted and may not be actively trading.

TradeUP Acquisition (UPTD) Competitors

TradeUP Acquisition logo

UPTD vs. CVM, OMGA, AIM, FRTX, APTO, ONVO, GENE, SQZ, SRNE, and KRBP

Should you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include CEL-SCI (CVM), Omega Therapeutics (OMGA), AIM ImmunoTech (AIM), Fresh Tracks Therapeutics (FRTX), Aptose Biosciences (APTO), Organovo (ONVO), Genetic Technologies (GENE), SQZ Biotechnologies (SQZ), Sorrento Therapeutics (SRNE), and Kiromic BioPharma (KRBP). These companies are all part of the "biological products, except diagnostic" industry.

TradeUP Acquisition vs. Its Competitors

CEL-SCI (NYSE:CVM) and TradeUP Acquisition (NASDAQ:UPTD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

CEL-SCI has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, TradeUP Acquisition has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CEL-SCIN/AN/A-$26.92M-$12.61-0.26
TradeUP AcquisitionN/AN/A-$1MN/AN/A

In the previous week, CEL-SCI had 1 more articles in the media than TradeUP Acquisition. MarketBeat recorded 1 mentions for CEL-SCI and 0 mentions for TradeUP Acquisition. TradeUP Acquisition's average media sentiment score of 0.67 beat CEL-SCI's score of 0.00 indicating that TradeUP Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
CEL-SCI Neutral
TradeUP Acquisition Positive

TradeUP Acquisition's return on equity of 0.00% beat CEL-SCI's return on equity.

Company Net Margins Return on Equity Return on Assets
CEL-SCIN/A -238.05% -104.65%
TradeUP Acquisition N/A N/A -3.38%

12.1% of CEL-SCI shares are held by institutional investors. Comparatively, 35.0% of TradeUP Acquisition shares are held by institutional investors. 9.9% of CEL-SCI shares are held by company insiders. Comparatively, 55.1% of TradeUP Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

TradeUP Acquisition beats CEL-SCI on 6 of the 8 factors compared between the two stocks.

Get TradeUP Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPTD vs. The Competition

MetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$1.91M$210.67M$5.59B$9.00B
Dividend YieldN/AN/A5.25%4.03%
P/E RatioN/AN/A27.5420.18
Price / SalesN/A261.08415.83171.78
Price / CashN/A22.4437.0657.97
Price / Book-0.556.138.105.61
Net Income-$1M-$96.61M$3.17B$248.59M

TradeUP Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPTD
TradeUP Acquisition
N/A$0.88
+1.1%
N/A-29.7%$1.91MN/A0.002,021
CVM
CEL-SCI
0.0842 of 5 stars
$2.49
-1.2%
N/A-92.4%$7.55MN/A-5.1943High Trading Volume
OMGA
Omega Therapeutics
2.1401 of 5 stars
$0.13
-21.8%
$8.50
+6,700.0%
-93.0%$6.92M$8.10M-0.09120Gap Up
AIM
AIM ImmunoTech
1.4884 of 5 stars
$8.85
-3.5%
$275.00
+3,007.3%
-74.4%$6.76M$146K-18.8320Gap Up
FRTX
Fresh Tracks Therapeutics
N/A$0.94
-0.5%
N/A+1.6%$5.59M$10.06M-0.6620
APTO
Aptose Biosciences
1.1931 of 5 stars
N/A$6.00
+∞
N/A$3.66MN/A-0.5831Gap Down
High Trading Volume
ONVO
Organovo
N/AN/AN/AN/A$3.47M$122K-2.4020Gap Up
GENE
Genetic Technologies
N/A$0.77
flat
N/AN/A$3.37M$7.66M0.0050High Trading Volume
SQZ
SQZ Biotechnologies
N/A$0.03
flat
N/A-24.3%$826K$18.16M-0.011,620News Coverage
SRNE
Sorrento Therapeutics
0.7011 of 5 stars
$0.00
-7.1%
N/A-88.8%$717K$60.32M0.00800Gap Down
High Trading Volume
KRBP
Kiromic BioPharma
N/AN/AN/AN/A$330KN/A-0.0660Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:UPTD) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners